Global Benign Prostatic Hyperplasia Devices Market - Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Benign Prostatic Hyperplasia Devices Market

The benign prostatic hyperplasia devices market is expected to witness market growth at a rate of 14.1% in the forecast period of 2021 to 2028. Data Bridge Market Research report on benign prostatic hyperplasia devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the number geriatric population is escalating the growth of benign prostatic hyperplasia devices market.

Benign prostatic hyperplasia (BPH) is defined as a non-cancerous enlargement of prostate gland. Benign prostatic hypertrophy is also called benign prostatic obstruction or benign prostatic hypertrophy. It is a condition that mostly occurs in men. The prostate gland typically goes through two major growth stages as man ages. The first phase occurs at the onset of puberty, when the prostate gland doubles in size, while the second phase of growth occurs around age 25 and continues for most of a man's life. BPH usually develop with the second stage of growth.

Major factors that are expected to boost the growth of the benign prostatic hyperplasia devices market in the forecast period are the rise in the prevalence of benign prostatic hyperplasia amongst men along with increasing risk factors. Furthermore, surge in the demand for minimally invasive treatment, developments associated with innovate and advanced BPH treatment devices is further anticipated to propel the growth of the benign prostatic hyperplasia devices market. Moreover, the growing popularity of robotic assistance surgical techniques and presence of favourable reimbursement facilities is further estimated to cushion the growth of the benign prostatic hyperplasia devices market. On other hand, the high cost associated with benign prostatic hyperplasia devices and side effects related with the BPH medications is further projected to impede the growth of the benign prostatic hyperplasia devices market in the timeline period.

In addition, rising healthcare sector in emerging economies and technological advancement related with benign prostatic hyperplasia devices will further provide potential opportunities for the growth of the benign prostatic hyperplasia devices market in the coming years. However, the less awareness about prostate health among men and product recalls might further challenge the benign prostatic hyperplasia devices market in the near future.

This benign prostatic hyperplasia devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on benign prostatic hyperplasia devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Benign Prostatic Hyperplasia Devices Market Scope and Market Size

The benign prostatic hyperplasia devices market is segmented on the basis of procedure type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of procedure type, the benign prostatic hyperplasia devices market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift (PUL), prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others.
• On the basis of end user, the benign prostatic hyperplasia devices market is bifurcated into hospitals and clinics, ambulatory surgical centres and others.

Benign Prostatic Hyperplasia Devices Market Country Level Analysis

The benign prostatic hyperplasia devices market is analysed and market size insights and trends are provided by country, procedure type and end user as referenced above.

The countries covered in benign prostatic hyperplasia devices market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

The country section of the benign prostatic hyperplasia devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The benign prostatic hyperplasia devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for benign prostatic hyperplasia devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the benign prostatic hyperplasia devices market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Benign Prostatic Hyperplasia Devices Market Share Analysis

The benign prostatic hyperplasia devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to benign prostatic hyperplasia devices market.

The major players covered in the benign prostatic hyperplasia devices market report are KARL STORZ, OmniGuide Holdings, Inc., Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, Medifocus Inc., biolitec AG, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-33382